AbbVie | ABBV - Market Capitalization

Stock Price
213.76
Daily Change
4.35 2.08%
Monthly
4.93%
Yearly
15.64%
Q2 Forecast
206.16

AbbVie reported $380.82B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 364.22B 20.46B May/2026
Abbott USD 178.41B 39.46B Mar/2026
ALKERMES USD 5.66B 217M May/2026
Amgen USD 189.89B 13.64B Mar/2026
AstraZeneca USD 301.25B 13.1B Mar/2026
Biogen USD 26.9B 1.09B Mar/2026
BioMarin Pharmaceutical USD 10.18B 683M May/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Coherus Biosciences USD 172M 19M Dec/2025
Eisai JPY 1.25T 171.13B May/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
Gilead Sciences USD 167.39B 5.6B May/2026
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Infinity Pharmaceuticals USD 0 0 Apr/2026
J&J USD 579.15B 78.91B Mar/2026
Merck USD 297.1B 35.84B Mar/2026
Neurocrine Biosciences USD 15.15B 1.9B May/2026
Novartis USD 232.75B 75B May/2026
Pacira USD 915M 149M Mar/2026
Perrigo USD 1.58B 265M May/2026
Pfizer USD 147.4B 6.42B May/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.27B 605.48M Mar/2026
UCB EUR 46.41B 13.94B Dec/2025
Ultragenyx Pharmaceutical USD 2.06B 1000K May/2026
United Therapeutics USD 28.08B 2.9B May/2026
Vertex Pharmaceuticals USD 113.58B 1000K May/2026
Zoetis USD 39.98B 9.73B May/2026